As of 2025-07-13, the Intrinsic Value of Greenwich Lifesciences Inc (GLSI) is -6.20 USD. This GLSI valuation is based on the model Peter Lynch Fair Value. With the current market price of 10.84 USD, the upside of Greenwich Lifesciences Inc is -157.18%.
Based on its market price of 10.84 USD and our intrinsic valuation, Greenwich Lifesciences Inc (GLSI) is overvalued by 157.18%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -6.20 - -6.20 | -6.20 | -157.18% |
| P/E | (12.64) - (23.40) | (17.23) | -259.0% |
| DDM - Stable | (9.88) - (40.37) | (25.13) | -331.8% |
| DDM - Multi | (4.42) - (14.65) | (6.87) | -163.3% |
| Market Cap (mil) | 144.93 |
| Beta | 1.35 |
| Outstanding shares (mil) | 13.37 |
| Enterprise Value (mil) | 142.18 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.77% |
| Cost of Debt | 5.00% |
| WACC | 6.72% |